Don't Miss: Best Chance to Access Midcap Stocks Research at 80% OFF
Here is the latest financial fact sheet of SUVEN LIFE SCIENCES. For more details, see the SUVEN LIFE SCIENCES quarterly results and SUVEN LIFE SCIENCES share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | -1.2 |
No. of shares | m | 218.07 |
1 Week | % | -5.3 |
1 Month | % | 8.5 |
1 Year | % | 95.2 |
52 week H/L | Rs | 128.8/55.0 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
SUVEN LIFE SCIENCES EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 338 | 335 | 109 | 124 | 94 | |
Low | Rs | 169 | 20 | 19 | 70 | 45 | |
Sales per share (Unadj.) | Rs | 22.4 | 1.1 | 1.1 | 0.8 | 0.6 | |
Earnings per share (Unadj.) | Rs | -1.9 | -7.4 | -5.7 | -8.4 | -5.4 | |
Diluted earnings per share | Rs | -1.1 | -4.3 | -3.3 | -5.6 | -5.4 | |
Cash flow per share (Unadj.) | Rs | -0.8 | -7.1 | -5.3 | -8.1 | -5.1 | |
Dividends per share (Unadj.) | Rs | 1.50 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.88 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0.6 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 18.8 | 11.3 | 5.6 | 6.6 | 17.2 | |
Adj. book value per share | Rs | 11.0 | 6.6 | 3.3 | 4.4 | 17.2 | |
Shares outstanding (eoy) | m | 127.28 | 127.28 | 127.28 | 145.38 | 218.07 | |
Price / Sales ratio | x | 11.3 | 156.8 | 60.6 | 119.6 | 111.8 | |
Avg P/E ratio | x | -135.0 | -24.0 | -11.3 | -11.6 | -12.8 | |
P/CF ratio (eoy) | x | -332.4 | -25.1 | -12.0 | -12.0 | -13.5 | |
Price / Book Value ratio | x | 13.5 | 15.8 | 11.5 | 14.7 | 4.0 | |
Dividend payout | % | -79.9 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 32,269 | 22,605 | 8,168 | 14,164 | 15,131 | |
Total wages/salary | Rs m | 365 | 174 | 185 | 210 | 186 |
SUVEN LIFE SCIENCES INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 2,857 | 144 | 135 | 118 | 135 | |
Other income | Rs m | 272 | 140 | 78 | 16 | 84 | |
Total revenues | Rs m | 3,129 | 285 | 212 | 134 | 220 | |
Gross profit | Rs m | -110 | -1,157 | -799 | -1,185 | -1,196 | |
Depreciation | Rs m | 142 | 42 | 43 | 44 | 65 | |
Interest | Rs m | 19 | 6 | 9 | 7 | 5 | |
Profit before tax | Rs m | 2 | -1,064 | -775 | -1,220 | -1,183 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 241 | -122 | -53 | 0 | 0 | |
Profit after tax | Rs m | -239 | -942 | -722 | -1,220 | -1,183 | |
Gross profit margin | % | -3.8 | -802.8 | -593.1 | -1,000.8 | -883.6 | |
Effective tax rate | % | 15,423.1 | 11.4 | 6.9 | 0 | 0 | |
Net profit margin | % | -8.4 | -653.6 | -535.3 | -1,030.0 | -873.5 |
SUVEN LIFE SCIENCES BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 3,982 | 1,595 | 1,966 | 1,605 | 3,455 | |
Current liabilities | Rs m | 1,570 | 1,200 | 1,098 | 1,022 | 1,050 | |
Net working cap to sales | % | 84.5 | 273.8 | 643.8 | 492.1 | 1,776.0 | |
Current ratio | x | 2.5 | 1.3 | 1.8 | 1.6 | 3.3 | |
Inventory Days | Days | 285 | 2,312 | 2 | 1,402 | 3,948 | |
Debtors Days | Days | 34 | 575 | 477 | 400 | 218 | |
Net fixed assets | Rs m | 224 | 1,159 | 257 | 414 | 1,373 | |
Share capital | Rs m | 127 | 127 | 127 | 145 | 218 | |
"Free" reserves | Rs m | 2,264 | 1,306 | 584 | 816 | 3,535 | |
Net worth | Rs m | 2,391 | 1,433 | 711 | 961 | 3,753 | |
Long term debt | Rs m | 18 | 11 | 4 | 0 | 0 | |
Total assets | Rs m | 4,206 | 2,755 | 2,223 | 2,019 | 4,828 | |
Interest coverage | x | 1.1 | -192.1 | -81.3 | -181.1 | -218.8 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0 | |
Sales to assets ratio | x | 0.7 | 0.1 | 0.1 | 0.1 | 0 | |
Return on assets | % | -5.2 | -34.0 | -32.0 | -60.1 | -24.4 | |
Return on equity | % | -10.0 | -65.7 | -101.5 | -126.9 | -31.5 | |
Return on capital | % | 0.9 | -73.3 | -107.1 | -126.2 | -31.4 | |
Exports to sales | % | 196.8 | 94.2 | 69.1 | 44.7 | 40.4 | |
Imports to sales | % | 63.0 | 877.5 | 547.1 | 933.6 | 839.8 | |
Exports (fob) | Rs m | 5,622 | 136 | 93 | 53 | 55 | |
Imports (cif) | Rs m | 1,799 | 1,265 | 737 | 1,106 | 1,137 | |
Fx inflow | Rs m | 5,622 | 136 | 93 | 53 | 55 | |
Fx outflow | Rs m | 1,799 | 1,265 | 737 | 1,106 | 1,137 | |
Net fx | Rs m | 3,822 | -1,129 | -644 | -1,053 | -1,082 |
SUVEN LIFE SCIENCES CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | -526 | -1,346 | -960 | -1,275 | -1,031 | |
From Investments | Rs m | 371 | 1,462 | 558 | -222 | -2,606 | |
From Financial Activity | Rs m | 45 | 28 | 349 | 1,457 | 3,955 | |
Net Cashflow | Rs m | -177 | 144 | -53 | -41 | 317 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Venkateswarlu Jasti | COMP SEC: Shrenik Soni | YEAR OF INC: 1989 | BSE CODE: 530239 | FV (Rs): 1 | DIV YIELD (%): - |
Read: SUVEN LIFE SCIENCES 2022-23 Annual Report Analysis
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare SUVEN LIFE SCIENCES With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
It was indeed a volatile trading session for Indian share markets today. Benchmark indices swung between gains and losses throughout the day.